Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Litholife is a Brazilian biotechnology company specializing in the development and commercialization of products derived from Lithothamnium calcareum, a marine red alga. The company leverages proprietary extraction and processing technologies to produce high-purity, bioavailable mineral supplements, particularly calcium and magnesium, for human and animal nutrition. Their portfolio serves the pharmaceutical, nutraceutical, and food industries, providing raw materials and finished products aimed at improving bone health and metabolic function. Litholife is recognized for its commitment to environmental sustainability, utilizing eco-friendly harvesting methods for its marine-sourced ingredients. The company's products are scientifically validated to offer superior absorption compared to traditional mineral sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Litholife.